Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,667
Closed -$646K 69
2021
Q1
$646K Sell
11,667
-119,800
-91% -$7.29M 0.13% 47
2020
Q4
$8.41M Buy
131,467
+8,134
+7% +$498K 1.75% 20
2020
Q3
$7.21M Buy
123,333
+21,666
+21% +$1.6M 2.22% 18
2020
Q2
$11.3M Sell
101,667
-1,666
-2% -$119K 3.16% 12
2020
Q1
$6.96M Buy
103,333
+33,333
+48% +$3.36M 2.64% 14
2019
Q4
$8.57M Buy
70,000
+25,000
+56% +$3.24M 1.96% 20
2019
Q3
$4.72M Buy
+45,000
New +$4.49M 1.23% 20
2019
Q1
Sell
-20,000
Closed -$1.86M 25
2018
Q4
$1.86M Sell
20,000
-37,333
-65% -$5.33M 0.76% 18
2018
Q3
$10.7M Buy
57,333
+15,666
+38% +$4.47M 3.05% 14
2018
Q2
$17.5M Buy
41,667
+36,179
+659% +$12.2M 5.85% 6
2018
Q1
$1.65M Buy
+5,488
New +$1.52M 0.78% 26

Other funds holding OPTN

Tamarack Advisers's OPTN Position: Q2 2021 in Review

Tamarack Advisers sold out of OptiNose (OPTN) in Q2 2021, closing a stake of 11,667 shares — an estimated $646K sold.

Tamarack Advisers first reported a position in OPTN in Q1 2018 and held it in 11 quarters. The position peaked at $17.5M in Q2 2018. 64 funds tracked by Wall St. Rank hold OPTN as of Q2 2021.

  • Tamarack Advisers reported no remaining OptiNose position as of Q2 2021 after selling out during the quarter.
  • Tamarack Advisers sold 11,667 OptiNose shares in Q2 2021, an estimated $646K.
  • Tamarack Advisers first reported a position in OptiNose in Q1 2018 and held it in 11 quarters.
  • Tamarack Advisers's OptiNose position peaked at $17.5M in Q2 2018.
  • 64 funds tracked by Wall St. Rank held OptiNose as of Q2 2021.

Based on Tamarack Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.